Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

NCT00791271 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Decitabine
DRUG: Pegylated Interferon Alpha-2b

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]